Standard
A subclass of HER1 ligands is a prognostic marker for survival in bladder cancer patients. / Thøgersen, Vibeke Bech; Sørensen, Boe Sandahl; Poulsen, Steen Seier; Ørntoft, T.F.; Wolf, H.; Nexø, E.
I:
Cancer Research, Nr. 61, 2001, s. 6227-6233.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Thøgersen, VB, Sørensen, BS, Poulsen, SS, Ørntoft, TF, Wolf, H & Nexø, E 2001, 'A subclass of HER1 ligands is a prognostic marker for survival in bladder cancer patients', Cancer Research, nr. 61, s. 6227-6233.
APA
Thøgersen, V. B., Sørensen, B. S., Poulsen, S. S., Ørntoft, T. F., Wolf, H., & Nexø, E. (2001). A subclass of HER1 ligands is a prognostic marker for survival in bladder cancer patients. Cancer Research, (61), 6227-6233.
Vancouver
Thøgersen VB, Sørensen BS, Poulsen SS, Ørntoft TF, Wolf H, Nexø E. A subclass of HER1 ligands is a prognostic marker for survival in bladder cancer patients. Cancer Research. 2001;(61):6227-6233.
Author
Thøgersen, Vibeke Bech ; Sørensen, Boe Sandahl ; Poulsen, Steen Seier ; Ørntoft, T.F. ; Wolf, H. ; Nexø, E. / A subclass of HER1 ligands is a prognostic marker for survival in bladder cancer patients. I: Cancer Research. 2001 ; Nr. 61. s. 6227-6233.
Bibtex
@article{76fe8ff074c711dbbee902004c4f4f50,
title = "A subclass of HER1 ligands is a prognostic marker for survival in bladder cancer patients",
abstract = "Anatomi",
author = "Th{\o}gersen, {Vibeke Bech} and S{\o}rensen, {Boe Sandahl} and Poulsen, {Steen Seier} and T.F. {\O}rntoft and H. Wolf and E. Nex{\o}",
year = "2001",
language = "English",
pages = "6227--6233",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research",
number = "61",
}
RIS
TY - JOUR
T1 - A subclass of HER1 ligands is a prognostic marker for survival in bladder cancer patients
AU - Thøgersen, Vibeke Bech
AU - Sørensen, Boe Sandahl
AU - Poulsen, Steen Seier
AU - Ørntoft, T.F.
AU - Wolf, H.
AU - Nexø, E.
PY - 2001
Y1 - 2001
N2 - Anatomi
AB - Anatomi
M3 - Journal article
SP - 6227
EP - 6233
JO - Cancer Research
JF - Cancer Research
SN - 0008-5472
IS - 61
ER -
